Technology | October 10, 2011

At RSNA 2011, Hologic will feature its Selenia Dimensions 3-D breast tomosynthesis technology. It is designed to help clinicians in catching breast cancers earlier and in significantly reducing the number of unnecessary diagnostic work-ups.

Launched in internationally markets in 2008, Selenia Dimensions breast tomosynthesis was approved for sale in the United States in 2011. Selenia Dimensions breast tomosynthesis delivers the exceptional 2-D images and, for the first time ever, allows a radiologist to offer their patients a conventional 2-D digital mammogram and a 3-D tomosynthesis exam in one compression in seconds. The combination of measurable improvements in accuracy and detection, and improved sensitivity, makes the new system a superior system vs. conventional digital mammography systems.

Unlike prior-generation mammography systems which generate two-dimensional images, a breast tomosynthesis system produces three-dimensional images which are intended to reveal the inner architecture of the breast, free from the distortion typically caused by tissue shadowing or density.

Hologic is offering five 90 minute programs combining lectures and hands-on experience reading 3-D breast tomosynthesis cases. The programs are designed for radiologists, administrators, technologists and others interested in learning more about this recently approved breast cancer screening and diagnosis technology.

More than a dozen scientific papers and poster session by clinicians using tomosynthesis in their practice will be presented at RSNA. Consult the RSNA Meeting Program Guide for times and places.

For more information: www.hologic.com


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
Subscribe Now